TRIAMINIC NIGHT TIME COLD & COUGH OTC
Generic Name and Formulations:
Diphenhydramine HCl 6.25mg, phenylephrine HCl 2.5mg; per 5mL; liq; alcohol-free; grape-flavored; contains sodium 6mg/5mL.
Novartis Consumer Health
Indications for TRIAMINIC NIGHT TIME COLD & COUGH:
Rhinorrhea, congestion, cough, allergy symptoms.
<4yrs: do not use. 4–6yrs: individualize. 6–12yrs: 10mL, repeat every 4hrs as needed; max 6 doses/24hrs.
Children <4yrs old. During or within 14 days of MAOIs. Concomitant diphenhydramine products (including topicals). For use as a sedative hypnotic.
Hypertension. Cardiovascular disease. Thyroid disease. Diabetes. Glaucoma. Asthma. Lower respiratory disorders. Discontinue if symptoms worsen or persist for ≥7 days.
Antihistamine + sympathomimetic.
See Contraindications. Hypertensive crisis with MAOIs. β-blockers may increase pressor effects of sympathomimetics. Antihypertensives antagonized. Increased CNS effects with other CNS depressants.
Drowsiness, anticholinergic effects, dizziness, nervousness, insomnia, excitability in children.
Endocrinology Advisor Articles
- Cushing Syndrome Results in Poor Quality of Life Even After Remission
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Low Predictive Power of Biomarkers for Estimated Glomerular Filtration Rate Decline
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Link Between Gestational Diabetes and Risk for CVD and Diabetes in Hispanic/Latina Population
- Clinical Characteristics Altering Risks and Benefits of Sulfonylureas and Thiazolidinedione Therapy in T2D
- 6 Factors Related to Inclusion in Health Care Workplace Identified
- Weight Gain After Quitting Smoking May Increase Risk for T2D